Product Information

Product NameMosapride
Structure
Cas NO112885-41-3
Molecular Weight421.897
Molecular FormulaC21H25ClFN3O3
Therap.Cat : Mosapride is under investigation for the treatment and prevention of Postoperative Ileus and Gastric Peroral Endoscopic Pyloromyotomy (G-POEM). Mosapride has been investigated for the treatment and diagnostic of Constipation, Type 2 Diabetes, Functional Dyspepsia, Functional Constipation, and Epigastric Pain Syndrome, among others.